Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy.
Anja SchorkJanine SaynischAndreas VosselerBenjamin Assad JaghutrizNils HeyneAndreas PeterHans-Ulrich HäringNorbert StefanAndreas FritscheFerruh ArtuncPublished in: Cardiovascular diabetology (2019)
Body weight reduction under the treatment with SGLT2-inhibitors is caused by reduction of adipose tissue mass and transient loss of extracellular fluid, which is accompanied by upregulation of renin-angiotensin-aldosterone system (RAAS). Permanent loss of extracellular water does not occur under SGLT2 inhibition.
Keyphrases
- body composition
- angiotensin converting enzyme
- angiotensin ii
- body weight
- type diabetes
- adipose tissue
- resistance training
- bone mineral density
- insulin resistance
- high fat diet
- cardiovascular disease
- poor prognosis
- cell proliferation
- high resolution
- glycemic control
- skeletal muscle
- cerebral ischemia
- metabolic syndrome
- blood brain barrier
- weight loss
- mass spectrometry
- high intensity